老年新发透析患者的血管通路放置与死亡率
该研究基于2007-2011年美国大型透析组织的新发血液透析患者数据,分析年龄≥80岁患者血管通路类型转换模式及其与死亡率的关系。在8356例≥80岁且透析超过1年的患者中,初始使用动静脉瘘/人工血管或由中心静脉导管置入动静脉瘘者死亡率低于持续使用导管者;由导管置入动静脉瘘与初始使用动静脉瘘的死亡率相似,且导管使用时间越长生存越差。
要点
- ≥80岁新发透析患者中,初始AVF/AVG或由CVC置入AVF者死亡率低于持续CVC者
- 由CVC置入AVF与初始AVF使用的死亡率相似
- CVC使用时间延长与生存率逐步恶化相关
核心结论
- 在≥80岁新发血液透析患者中,透析第一年内由中心静脉导管置入动静脉瘘与初始使用动静脉瘘的死亡率相似。
- 初始使用中心静脉导管、后续置入动静脉瘘可能是老年血液透析患者可接受的选择。
研究设计与样本
- 回顾性队列研究,纳入2007-2011年一家大型全国透析组织的新发血液透析患者。
- 总体队列100 804例,分析透析开始后1年内血管通路类型转换模式。
- 亚组分析纳入8356例年龄≥80岁且治疗超过1年的患者,采用多变量生存模型评估通路转换与死亡率的关系。
主要发现
- 在总体队列中,动静脉瘘/人工血管作为主要血管通路的患病率在透析第一年内增加,此后趋于平稳。
- 在≥80岁且治疗超过1年的患者中,初始使用AVF/AVG及由CVC置入AVF者死亡率低于持续使用CVC者。
- 以透析第一年内由CVC置入AVF者为参照,初始使用AVF者死亡率相似。
- CVC使用时间越长,生存率逐步恶化。
临床怎么用
- 对于≥80岁新发血液透析患者,可考虑初始使用CVC、后续置入AVF作为血管通路策略。
- 应尽量减少CVC使用时间,以降低死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Arteriovenous fistulas (AVFs) are the preferred vascular access type in most hemodialysis patients. However, the optimal vascular access type in octogenarians and older (≥80 years) hemodialysis patients remains widely debated given their limited life expectancy and lower AVF maturation rates. METHODS: Among incident hemodialysis patients receiving care in a large national dialysis organization during 2007-2011, we examined patterns of vascular access type conversion in 1 year following dialysis initiation in patients <80 versus ≥80 years of age. Among a subcohort of patients ≥80 years of age, we examined the association between vascular access type conversion and mortality using multivariable survival models. RESULTS: In the overall cohort of 100 804 patients, the prevalence of AVF/arteriovenous graft (AVG) as the primary vascular access type increased during the first year of hemodialysis, but plateaued thereafter. Among 8356 patients ≥80 years of age and treated for >1 year, those with initial AVF/AVG use and placement of AVF from a central venous catheter (CVC) had lower mortality compared with patients with persistent CVC use. When the reference group was changed to patients who had AVF placement from a CVC in the first year of dialysis, those with initial AVF use had similar mortality. A longer duration of CVC use was associated with incrementally worse survival. CONCLUSIONS: Among incident hemodialysis patients ≥80 years of age, placement of an AVF from a CVC within the first year of dialysis had similar mortality compared with initial AVF use. Our data suggest that initial CVC use with later placement of an AVF may be an acceptable option among elderly hemodialysis patients.
引用
- Ko GJ, Rhee CM, Obi Y, et al. Vascular access placement and mortality in elderly incident hemodialysis patients. Nephrol Dial Transplant. 2020. PMID: 30107612. doi:10.1093/ndt/gfy254
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。